We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$963M
AUM Growth
+$37.8M
Cap. Flow
+$3.99M
Cap. Flow %
0.41%
Top 10 Hldgs %
22.81%
Holding
263
New
13
Increased
78
Reduced
90
Closed
5

Top Buys

Rank Stock Value
1
SSNC icon
SS&C Technologies
SSNC
+$2.27M
2
ADBE icon
Adobe
ADBE
+$1.69M
3
JPM icon
JPMorgan Chase
JPM
+$1.48M
4
ALC icon
Alcon
ALC
+$1.35M
5
BDX icon
Becton Dickinson
BDX
+$873K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$3.28M
2
AL
Air Lease Corp
AL
+$2M
3
DD icon
DuPont de Nemours
DD
+$616K
4
AFL icon
Aflac
AFL
+$611K
5
XOM icon
ExxonMobil
XOM
+$439K

Sector Composition

Rank Sector Weight
1 Technology 17.22%
2 Healthcare 16.87%
3 Industrials 10.43%
4 Consumer Staples 8.73%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIDD icon
26
Middleby
MIDD
$6.27B
$11.4M 1.18%
83,721
-142
-0.2% -$19.1K
ROP icon
27
Roper Technologies
ROP
$38.8B
$11.1M 1.15%
30,201
-1,071
-3% -$380K
SYK icon
28
Stryker
SYK
$129B
$11M 1.14%
53,360
+73
+0.1% +$13.9K
TMO icon
29
Thermo Fisher Scientific
TMO
$209B
$10.8M 1.12%
36,846
+228
+0.6% +$62.8K
TEL icon
30
TE Connectivity
TEL
$62.9B
$10.4M 1.08%
108,458
+6,307
+6% +$569K
DLTR icon
31
Dollar Tree
DLTR
$25.1B
$10.2M 1.06%
94,920
-1,212
-1% -$127K
GIS icon
32
General Mills
GIS
$19.3B
$9.97M 1.03%
189,770
-1,355
-0.7% -$70K
VZ icon
33
Verizon
VZ
$195B
$9.72M 1.01%
170,168
+40
+0% +$2.31K
GOOG icon
34
Alphabet (Google) Class C
GOOG
$4.59T
$9.7M 1.01%
179,520
+760
+0.4% +$43.8K
XOM icon
35
ExxonMobil
XOM
$638B
$9.69M 1.01%
126,488
-5,670
-4% -$439K
PEP icon
36
PepsiCo
PEP
$190B
$9.53M 0.99%
72,673
+83
+0.1% +$10.6K
NEE icon
37
NextEra Energy
NEE
$182B
$9.47M 0.98%
184,920
+616
+0.3% +$30.3K
RTN
38
DELISTED
Raytheon Company
RTN
$9.01M 0.94%
51,842
-635
-1% -$114K
ABT icon
39
Abbott
ABT
$182B
$8.83M 0.92%
104,945
-1,082
-1% -$85.2K
AFL icon
40
Aflac
AFL
$63.7B
$8.81M 0.92%
160,786
-11,859
-7% -$611K
MRK icon
41
Merck
MRK
$316B
$8.14M 0.85%
101,726
+95
+0.1% +$7.27K
MCD icon
42
McDonald's
MCD
$191B
$7.74M 0.8%
37,279
-42
-0.1% -$8.32K
DHR icon
43
Danaher
DHR
$137B
$7.64M 0.79%
60,315
-738
-1% -$87.4K
QQQ icon
44
Invesco QQQ Trust
QQQ
$485B
$7.48M 0.78%
40,076
-1,683
-4% -$310K
IDXX icon
45
Idexx Laboratories
IDXX
$46.4B
$7.26M 0.75%
26,357
-135
-0.5% -$33.3K
GILD icon
46
Gilead Sciences
GILD
$168B
$7.15M 0.74%
105,845
-868
-0.8% -$57.1K
CVS icon
47
CVS Health
CVS
$133B
$6.95M 0.72%
127,463
-4,222
-3% -$227K
JPM icon
48
JPMorgan Chase
JPM
$950B
$6.52M 0.68%
58,341
+13,450
+30% +$1.48M
SPGI icon
49
S&P Global
SPGI
$122B
$6.44M 0.67%
28,276
-34
-0.1% -$7.43K
MMM icon
50
3M
MMM
$93.6B
$5.85M 0.61%
40,360
+110
+0.3% +$16.9K

Similar funds

Boston Family Office's Q2 2019 Portfolio in Review

As of Q2 2019, Boston Family Office held 263 positions worth $963M, up 4.1% from $925M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Boston Family Office's Q2 2019 filing shows 13 new, 78 increased, 90 reduced and 5 closed positions. Its largest new stake was Alcon: 23,012 shares worth $1.43M. The largest sale was Celgene Corp, an estimated $3.28M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Family Office's largest Q2 2019 buy was Alcon: 23,012 shares worth $1.43M.
  • Boston Family Office added most to SS&C Technologies in Q2 2019, an estimated $2.27M increase.
  • Boston Family Office's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $3.28M.
  • Boston Family Office fully exited Air Lease Corp in Q2 2019, selling an estimated $2M.
  • Boston Family Office's ten largest holdings make up 23% of its $963M portfolio in Q2 2019.
  • Boston Family Office opened 13 new positions and closed 5 in Q2 2019.
  • Boston Family Office's portfolio value rose 4.1% quarter-over-quarter to $963M.

Based on Boston Family Office's 13F filing for Q2 2019, filed 30 Jul 2019.